Selected Financial Data
since 2005
Paying user area
Try for free
Abiomed Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
Abiomed Inc., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenue | Income (loss) from operations | Net income (loss) |
|---|---|---|---|
| Mar 31, 2022 | |||
| Mar 31, 2021 | |||
| Mar 31, 2020 | |||
| Mar 31, 2019 | |||
| Mar 31, 2018 | |||
| Mar 31, 2017 | |||
| Mar 31, 2016 | |||
| Mar 31, 2015 | |||
| Mar 31, 2014 | |||
| Mar 31, 2013 | |||
| Mar 31, 2012 | |||
| Mar 31, 2011 | |||
| Mar 31, 2010 | |||
| Mar 31, 2009 | |||
| Mar 31, 2008 | |||
| Mar 31, 2007 | |||
| Mar 31, 2006 | |||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
- Revenue
- There is a generally increasing trend in revenue over the years, with fluctuations in growth rates. Revenue nearly doubled from 2005 to 2010 and continued to grow steadily thereafter.
- Income (loss) from operations
- The company experienced losses in the early years but managed to turn a profit from 2011 onwards. The improvement in operating income indicates better cost management and efficiency.
- Net income (loss)
- Net income shows a similar pattern to operating income, with losses turning into profits from 2011. The significant increase in net income in 2014 and 2017 stands out as noteworthy events in the company's financial performance.
Balance Sheet: Assets
Abiomed Inc., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Mar 31, 2022 | ||
| Mar 31, 2021 | ||
| Mar 31, 2020 | ||
| Mar 31, 2019 | ||
| Mar 31, 2018 | ||
| Mar 31, 2017 | ||
| Mar 31, 2016 | ||
| Mar 31, 2015 | ||
| Mar 31, 2014 | ||
| Mar 31, 2013 | ||
| Mar 31, 2012 | ||
| Mar 31, 2011 | ||
| Mar 31, 2010 | ||
| Mar 31, 2009 | ||
| Mar 31, 2008 | ||
| Mar 31, 2007 | ||
| Mar 31, 2006 | ||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
- Current Assets:
- The trend in current assets shows a consistent increase over the years, with a significant rise from 2015 onwards, more than doubling by 2022. This indicates improving liquidity and potentially efficient working capital management.
- Total Assets:
- Similar to current assets, total assets demonstrate a steady growth trend throughout the period. The total assets have more than doubled from 2005 to 2022, reflecting the company's expansion and increased investment in assets.
Balance Sheet: Liabilities and Stockholders’ Equity
Abiomed Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Capital lease obligation | Stockholders’ equity | |
|---|---|---|---|---|
| Mar 31, 2022 | ||||
| Mar 31, 2021 | ||||
| Mar 31, 2020 | ||||
| Mar 31, 2019 | ||||
| Mar 31, 2018 | ||||
| Mar 31, 2017 | ||||
| Mar 31, 2016 | ||||
| Mar 31, 2015 | ||||
| Mar 31, 2014 | ||||
| Mar 31, 2013 | ||||
| Mar 31, 2012 | ||||
| Mar 31, 2011 | ||||
| Mar 31, 2010 | ||||
| Mar 31, 2009 | ||||
| Mar 31, 2008 | ||||
| Mar 31, 2007 | ||||
| Mar 31, 2006 | ||||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
- Current Liabilities:
- Showing a consistent increasing trend from 2005 to 2022, with some fluctuations. The values more than doubled from 2005 to 2022, indicating a growth in short-term obligations over the years.
- Total Liabilities:
- Experienced a similar upward trend, steadily rising from 2005 to 2022. The increase was notable, nearly tripling from the initial period.
- Capital Lease Obligation:
- There are only sporadic data points, making it difficult to infer a trend. A substantial amount is shown in 2012, suggesting a specific financial decision in that year regarding lease obligations.
- Stockholders' Equity:
- Displayed a general upward trajectory over the years, with significant growth particularly from 2014 onwards. Shareholders' equity saw a substantial increase, more than doubling from 2014 to 2022.
Cash Flow Statement
Abiomed Inc., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by (used for) operating activities | Net cash (used for) provided by investing activities | Net cash provided by (used for) financing activities |
|---|---|---|---|
| Mar 31, 2022 | |||
| Mar 31, 2021 | |||
| Mar 31, 2020 | |||
| Mar 31, 2019 | |||
| Mar 31, 2018 | |||
| Mar 31, 2017 | |||
| Mar 31, 2016 | |||
| Mar 31, 2015 | |||
| Mar 31, 2014 | |||
| Mar 31, 2013 | |||
| Mar 31, 2012 | |||
| Mar 31, 2011 | |||
| Mar 31, 2010 | |||
| Mar 31, 2009 | |||
| Mar 31, 2008 | |||
| Mar 31, 2007 | |||
| Mar 31, 2006 | |||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
- Net cash provided by (used for) operating activities
- The trend in net cash provided by operating activities has been volatile over the years, with periods of both negative and positive cash flows. The values show a gradual increase from negative values to positive values with a significant rise from 2015 onwards.
- Net cash (used for) provided by investing activities
- The net cash used for investing activities fluctuated notably, with a mix of positive and negative values over time. There was a steep decline in cash used for investing activities in 2008, followed by periods of recovery and subsequent downturns. The data indicates a large negative value in 2022, suggesting increased investing outflows.
- Net cash provided by (used for) financing activities
- Net cash from financing activities exhibits fluctuations across the years, with varying levels of cash flows. A significant positive spike is observed in 2007, followed by oscillations in subsequent years. The values turned negative in various periods, indicating financing activities requiring more cash outflows.
Per Share Data
Abiomed Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Mar 31, 2022 | |||
| Mar 31, 2021 | |||
| Mar 31, 2020 | |||
| Mar 31, 2019 | |||
| Mar 31, 2018 | |||
| Mar 31, 2017 | |||
| Mar 31, 2016 | |||
| Mar 31, 2015 | |||
| Mar 31, 2014 | |||
| Mar 31, 2013 | |||
| Mar 31, 2012 | |||
| Mar 31, 2011 | |||
| Mar 31, 2010 | |||
| Mar 31, 2009 | |||
| Mar 31, 2008 | |||
| Mar 31, 2007 | |||
| Mar 31, 2006 | |||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1, 2, 3 Data adjusted for splits and stock dividends.
- Basic Earnings per Share
- The data shows a fluctuating trend over the years, with negative values observed until 2012, and then a notable increase from 2013 onwards. The most significant leap in earnings per share occurred between 2014 and 2015, followed by further growth until 2019 where it peaked. A slight decline is seen in 2020 and 2021, with a noteworthy increase in 2022.
- Diluted Earnings per Share
- Similar to Basic Earnings per Share, Diluted Earnings per Share also displayed negative values at the beginning of the period, transitioning to positive figures from 2012 onwards. A remarkable surge is seen from 2014 to 2015, with a subsequent gradual increase until 2019. However, a decline is noted in 2020 and 2021, with a significant rise in 2022.
- Dividend per Share
- There is no data available for Dividend per Share across all the periods. It suggests that the company did not issue dividends during the analyzed timeframe.